Message Priming and Enrollment in, and Response to, a Smoking Cessation Program: A Pilot Study

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Smoking Cessation
Interventions
OTHER

Message Prime

Participants will be randomized to genetic prime messages or threat only message at the time of the intial telephone screen. Following phone screen, all eligibleparticipants will receive 13 weeks of Chantix with smoking cessation counseling.

OTHER

Message Prime

Particpants will be randomized into 1 of 2 groups. 1 group will recieve a message detailing the negative helaht consequenes of smoking and the other group will receive this information along with information about the genetic incluences on smoking behavior.

Trial Locations (1)

19104

Transdisciplinary Tobacco Use Research Center, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pennsylvania Department of Health

OTHER_GOV

collaborator

Pfizer

INDUSTRY

lead

University of Pennsylvania

OTHER